AI Governance Institute
← News
Research2026-11-16

Regulated Industries Need Agentic AI Governance Infrastructure Now

What happened

DIA Global Forum published Regulatory Affairs Operating System: Why Agentic AI is the Inescapable Logic of Modern Compliance, a detailed implementation framework co-authored by researchers from RegASK. The article maps a five-stage maturity model from manual tracking to fully orchestrated agent execution with human sign-off. It draws on RegASK's 2026 State of Regulatory Affairs and Compliance Report. Only about one in ten regulatory leaders can identify and respond to a new regulation within two days. Over 40% of managers and specialists need one to four weeks, and nearly one in five take longer than a month. Stage 4 has AI systems score regulatory risk and recommend actions for human approval. The authors say stage 4 is already technically achievable. Stage 5 is full end-to-end agent execution with audit trails. It requires integrated quality management and submission systems plus a mature governance framework. The piece explicitly aligns its performance measurement approach with the GOVERN and MEASURE functions of the NIST AI Risk Management Framework (AI RMF 1.0) and Playbook. It frames outcome-based KPIs such as right-first-time approval rates and signal detection speed as the successor to activity-based measures.

Why it matters

  • ·Regulated industries face a documentation gap: stage 4 and 5 agentic workflows produce decisions and actions that existing quality management and audit systems were not designed to capture. Regulators in pharma, medical devices, and financial services increasingly ask organizations to prove AI-assisted decisions are traceable. Most organizations currently lack the integrated audit trail infrastructure to do so.
  • ·The maturity benchmark data shows that most organizations are at stage 1 or 2, meaning they are poorly positioned to demonstrate controlled compliance posture. This matters for EU AI Act (Regulation (EU) 2024/1689) conformity assessments and for FDA software-as-a-medical-device reviews. Both require documented evidence of human oversight and change control across the AI system lifecycle.
  • ·Human approval gates are framed as a structural requirement, not a check-box. The article defines stage 5 as agents doing the work while humans approve it, not humans reviewing outputs after the fact. Organizations that conflate these two things risk deploying agentic workflows that do not satisfy the meaningful oversight expectations emerging in multiple jurisdictions.

Stay ahead of stories like this

Get every Global AI governance development like this one, plus the rest of the week's developments. Every Thursday.

Free every Thursday. Unsubscribe anytime.

Governance controls affected

What to do now

  • ☐Use the five-stage maturity model to assess where your regulatory affairs or compliance team currently sits, and document the finding for your AI governance committee.
  • ☐Confirm that your quality management or change control system can capture agent-generated audit entries, including which agent acted, what data it used, what it recommended, and which human approved the step.
  • ☐Identify every agentic workflow in regulatory affairs, pharmacovigilance, or compliance that currently routes outputs to human reviewers, and verify that the approval step is recorded in a system of record rather than in an email thread or chat message.
  • ☐Ask your legal and regulatory team whether your current KPIs for compliance functions (such as hours per dossier or revision rounds) can be supplemented with outcome-based measures that regulators could audit, such as detection speed and right-first-time rates.
  • ☐Review your AI incident response playbook to confirm it covers agentic workflows specifically, including procedures for cases where an agent routes an incorrect or incomplete impact memo before a human reviewer catches it.

What to watch next

Monitor whether health authority examiners in key jurisdictions begin issuing inspection observations related to AI-assisted regulatory tracking and submission workflows. Key jurisdictions include the FDA, the European Medicines Agency, and Japan's PMDA. The NIST AI Risk Management Framework (AI RMF 1.0) and Playbook GOVERN and MEASURE functions are voluntary today. However, their language is increasingly appearing in sector-specific guidance. Watch also for ICH Q10-aligned guidance updates addressing AI integration into pharmaceutical quality systems. Monitor the EU AI Act (Regulation (EU) 2024/1689) conformity assessment process as it matures. It may require documented stage-level evidence of human oversight in regulated workflows.

Related Coverage

Corporate Policy2026-11-16

IRS Pilot Shows Where AI Ends and Human Judgment Begins in Fraud Cases

The IRS is piloting an agentic AI tool to handle clerical steps in fraud case processing. This includes organizing taxpayer correspondence and summarizing responses. Human employees make all final decisions. The pilot is in development without a confirmed deployment timeline. The design explicitly reserves all case judgments for human staff.

Corporate Policy2026-11-15

Google Cloud's Policy MCP Server Lets AI Agents Rewrite Cloud Security Rules

Google Cloud has made its Organization Policy Model Context Protocol (MCP) server generally available. The server allows autonomous AI agents and automated pipelines to inspect, evaluate, and create policies and custom constraints across a Google Cloud environment. Enterprises connecting agents to this server must carefully limit what those agents are permitted to change, and log every evaluation and modification request.

Research2026-11-12

Vendor Custody, Delegated Authority, and the Agentic AI Accountability Gap

A peer-reviewed paper published in November 2026 by Springer Nature examines how accountability is distributed when AI agents make decisions on behalf of users and organizations. The research identifies four structural risks: delegated authority without clear ownership; vendor-controlled alignment measures that deployers cannot audit; limited inspection rights over agent behavior; and gaps in incident response responsibility. The findings have direct implications for vendor risk programs, human oversight requirements, and AI governance documentation.